SERPINB2 and breast cancer: The hot topic of cancer biomarkers has been recently debated[17,19-21,24]; among well-known biomarkers, uPA/PAI combination has long been regarded as prognostic indicator of BC, widely confirmed by prospective, retrospective and meta-analysis studies[49].